Clinical application of robotic surgical system in re-operation of thyroid cancer
10.3760/cma.j.cn115396-20221126-00406
- VernacularTitle:机器人外科手术系统在甲状腺癌再次手术中的临床应用
- Author:
Dan WANG
1
;
Jian ZHU
;
Jun WANG
;
Changrui LIU
;
Dongliang ZHAI
;
Shanshan MING
;
Qingqing HE
Author Information
1. 解放军联勤保障部队第九六〇医院甲状腺乳腺外科，济南 250031
- Keywords:
Thyroid neoplasms;
Recurrence;
Lymph nodes;
Da Vinci robot;
Reoperation
- From:
International Journal of Surgery
2023;50(5):344-348,C4
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the feasibility, safety and effectiveness of Da Vinci robotic surgical system in the reoperation of recurrent or residual thyroid cancer.Methods:Retrospective analysis was performed on the clinical data of 9 patients with Da Vinci robot-assisted reoperation for thyroid cancer in the 960th Hospital of the People′s Liberation Army of China from September 2018 to January 2022, the operation time, number of lymph nodes dissected, intraoperative blood loss, length of hospital stay, total postoperative drainage volume, incidence of complications, satisfaction with postoperative aesthetic effect, visual analyogue scale (VAS) score at the 24 h after surgery and number of recurrence during follow-up were counted.Results:The surgery time of 9 cases was (186.67±44.44) min, the number of lymph nodes cleared were (15.77±13.59), intraoperative blood loss was (21.11±16.91) mL, hospital stay were (10.67±3.32) days, total postoperative drainage was (286.94±90.85) mL. There was no complications, and all patients were satisfied with the postoperative cosmetic effect whose VAS score was (8.22±1.09), and VAS score was 0 to 3 (2.44±0.73) points, no recurrence during the follow-up period from 6 to 46 months.Conclusion:With adequate preoperative evaluation and an experienced surgeon team, the use of robots in recurrent or residual thyroid cancer resurgery is feasible, safe and effective.
